EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

A Case of Successful Kidney Transplant‐Alone in Primary Hyperoxaluria Type 1 Using Lumasiran

Karen Flores iD, Massini Merzkani, Samer Abdulkhalek, Farah Abuazzam, Anuja Java, Rowena Delos Santos, Rohan Paul, Joseph Gaut iD, Tarek Alhamad

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70464 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Karen Flores und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Washington University in St. Louis, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Hyperoxaluria, Primary, Kidney Failure, Chronic, RNA, Small Interfering. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Simultaneous liver‐kidney transplantation (SLKT) has been the standard of care for patients with end‐stage renal disease (ESRD) and primary hyperoxaluria type 1 (PH1). Lumasiran is a novel RNA interference (RNAi) therapy that targets glycolate oxidase and decreases oxalate production in the liver. Despite its availability, the use of RNAi with kidney transplant alone (KTA) for ESRD related to primary hyperoxaluria remains limited. We report a 39‐year‐old female with a history of KTA who presented with diarrhea and severe AKI. She rapidly progressed to anuria and allograft loss. Her kidney biopsy demonstrated calcium oxalate deposition. The patient was subsequently evaluated for a repeat kidney transplant. Given the morbidity associated with SLKT, RNAi therapy was pursued as an alternative. Initiation of Lumasiran reduced serum oxalate from 40 to 8 µmol/L, enabling successful KTA with immediate graft function. At 12 months post‐transplant, renal function remained stable (creatinine 0.82 mg/dL, serum oxalate

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHyperoxaluria, PrimaryKidney Failure, ChronicRNA, Small InterferingRNA InterferenceHumansFemaleAdultPrognosisLiver TransplantationKidney Function Tests

Substanzen

lumasiranRNA, Small Interfering

Autor:innen und Institutionen

  • Division of Nephrology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Department of Pathology, Washington University in St. Louis, St. Louis, Missouri, USA.

ORCID-Profile: Karen Flores, Joseph Gaut

Zitieren

APA

Flores, K., Merzkani, M., Abdulkhalek, S., Abuazzam, F., Java, A., Delos Santos, R., Paul, R., Gaut, J., & Alhamad, T. (2026). A Case of Successful Kidney Transplant‐Alone in Primary Hyperoxaluria Type 1 Using Lumasiran. Clinical Transplantation. https://doi.org/10.1111/ctr.70464

Vancouver

Flores K, Merzkani M, Abdulkhalek S, Abuazzam F, Java A, Delos Santos R, et al. A Case of Successful Kidney Transplant‐Alone in Primary Hyperoxaluria Type 1 Using Lumasiran. Clinical Transplantation. 2026. doi:10.1111/ctr.70464

BibTeX
@article{Flores2026,
  author = {Flores, Karen and Merzkani, Massini and Abdulkhalek, Samer and Abuazzam, Farah and Java, Anuja and Delos Santos, Rowena and Paul, Rohan and Gaut, Joseph and Alhamad, Tarek},
  title = {A Case of Successful Kidney Transplant‐Alone in Primary Hyperoxaluria Type 1 Using Lumasiran},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70464}
}
Kostenlos starten →